Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2026-02-20 @ 4:44 PM
Study NCT ID:
NCT05393895
Status:
COMPLETED
Last Update Posted:
2025-06-11
First Post:
2022-05-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Evaluation of the Safety of CSF-1 in Presbyopic Subjects
Sponsor:
Orasis Pharmaceuticals Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
21-150-0005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None